PharmaInformatic entwickelt Expertensysteme für forschende pharmazeutische Unternehmen. Unsere Expertensysteme erkennen frühzeitig die sinnvollen Substanz-Kandidaten und senken somit die Entwicklungskosten neuer Medikamenten drastisch.

Die Plattform-Technologie des Unternehmens beinhaltet Millionen von Substanzen verknüpft mit experimentellen Daten sowie mehrere Tausend 3D-Modelle von Biomolekülen. Proprietäre Methoden der ChemieInformatik und BioInformatik ermöglichen die Prognose des Wirkungsspektrum einer Substanz sowie dessen pharmakologische Eigenschaften. (mehr...)

  

 
MolScore-Drugs
An expert system to identify and prioritise suitable drug candidates.

  

 
MolScore-Antibiotics
 An expert system for
antibiotic research.

 


MolScore-Antivirals
An expert system for
antiviral research.

Meet representatives of PharmaInformatic

Kooperation-Partnering
“Drug Development”

8. May 2008, Hannover

 To arrange a meeting, please contact us.
 

 
Endotherm GmbH
and PharmaInformatic
announced collaboration
to develop and optimise
novel antiviral drugs
(read more).
 

Site map
 

 

“Innovative tools and service to accelerate drug discovery”

"Expert systems identify promising drug candidates"

 

PharmaInformatic develops expert systems for pharmaceutical companies. Our expert systems identify promising drug candidates at the earliest stage. This reduces failure rates and saves time and money.

Our platform technology contains millions of substances together with experimental data and thousands of 3D-models of biomolecules. Proprietary methods based on chemInformatics and bioInformatics allow the prediction of biological activity of a substance and its pharmacological properties.

PharmaInformatic´s ADME/Tox database contains more than 16.000 data entries.

News: